EUVIMEDEUVIMED entdecken
Crossref

P1.21-16 NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy

K. Danilov, D. Bansal, C. Ward, A. Al-Obaidi, T. Pluard, A. Tarasov, I. Valiev, V. Kushnarev, A. Makarova, A. Butusova, A. Love, K. Nomie und 3 weitere

Journal of Thoracic Oncology · 2023-11 · 18 (11) · S241

DOI: 10.1016/j.jtho.2023.09.402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Oncology, 2023-11. Verfasst von K. Danilov und 14 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Danilov, K., Bansal, D., Ward, C., Al-Obaidi, A., Pluard, T., Tarasov, A., Valiev, I., Kushnarev, V., Makarova, A., Butusova, A., Love, A., Nomie, K., Bagaev, A., Subramanian, J., & Fowler, N. (2023). P1.21-16 NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy. Journal of Thoracic Oncology, 18(11), S241. https://doi.org/10.1016/j.jtho.2023.09.402

Vancouver

Danilov K, Bansal D, Ward C, Al-Obaidi A, Pluard T, Tarasov A, et al. P1.21-16 NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy. Journal of Thoracic Oncology. 2023;18(11):S241. doi:10.1016/j.jtho.2023.09.402

BibTeX
@article{Danilov2023,
  author = {Danilov, K. and Bansal, D. and Ward, C. and Al-Obaidi, A. and Pluard, T. and Tarasov, A. and Valiev, I. and Kushnarev, V. and Makarova, A. and Butusova, A. and Love, A. and Nomie, K. and Bagaev, A. and Subramanian, J. and Fowler, N.},
  title = {P1.21-16 NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy},
  journal = {Journal of Thoracic Oncology},
  year = {2023},
  volume = {18},
  number = {11},
  pages = {S241},
  doi = {10.1016/j.jtho.2023.09.402}
}
Kostenlos starten →